Working… Menu
Trial record 1 of 1 for:    Saved Studies
Previous Study | Return to List | Next Study

Immunotherapy With IFx-Hu2.0 Vaccine for Advanced MCC or cSCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04160065
Recruitment Status : Recruiting
First Posted : November 12, 2019
Last Update Posted : July 13, 2021
H. Lee Moffitt Cancer Center and Research Institute
University of Southern California
Dana-Farber Cancer Institute
Huntsman Cancer Institute
Information provided by (Responsible Party):
Morphogenesis, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : June 2022